Related Experiment Videos
Tricyclic antidepressants in adolescent depression. A case report
1Department of Child and Adolescent Psychiatry, Institute of Psychiatry, London, United Kingdom.
European Child & Adolescent Psychiatry
|November 24, 1998
Summary
This case study details a young boy's difficult journey managing severe depression with various antidepressants. It highlights challenges with tricyclic antidepressants and successful treatment with dothiepin and lithium.
Area of Science:
- Child and Adolescent Psychiatry
- Pharmacology
- Clinical Medicine
Background:
- Severe depressive episodes in children and adolescents can present with complex somatic and psychotic features.
- Treatment resistance and adverse drug reactions are significant challenges in managing pediatric depression.
- Tricyclic antidepressants (TCAs) are a class of drugs used for depression, but their use in younger populations requires careful monitoring.
Observation:
- An 11-year-old boy experienced a severe depressive episode with somatic and psychotic symptoms.
- Initial treatment with amitriptyline yielded a clinical response but was complicated by electrocardiogram (ECG) changes and withdrawal syndrome.
- Subsequent trials of paroxetine, lofepramine, and trazodone were unsuccessful due to clinical deterioration, ECG changes, or priapism.
Findings:
- A combination of dothiepin and lithium achieved a good clinical response in the patient.
- ECG changes were deemed idiosyncratic to the medication, not ischemic.
- A dose-response relationship was observed with dothiepin.
- The patient successfully discontinued all medication after 26 months of treatment.
Implications:
- This case underscores the variability in pediatric response to antidepressant medications, particularly TCAs.
- Idiosyncratic reactions and withdrawal syndromes necessitate careful patient monitoring and individualized treatment strategies.
- Findings contribute to the understanding of TCA use in pediatric populations and may inform future treatment guidelines.